Rosemary (Turingan) Witkowski

VP, Assay Development and Innovation at Harbinger Health

Rosemary (Turingan) Witkowski has a strong background in molecular biology, with extensive experience in assay development and innovation. Rosemary currently holds the position of VP, Assay Development and Innovation at Harbinger Health since 2022. Prior to this, they worked at ANDE, starting in 2013 as the VP of Forensic and Clinical Biology, where they led the development, validation, and commercialization of various DNA analysis systems. Rosemary also served as the Senior Director of Molecular Biology, leading the Molecular Biology group and Assay Development team in enhancing the capabilities of ANDE's Rapid DNA Analysis Instrument.

Before joining ANDE, Rosemary worked at ANDE Corp. (formerly NetBio, Network Biosystems) as a Senior Scientist from 2009 to 2013. Rosemary played a crucial role in the selection and validation of materials and consumables and the development of assays for the company's human identification platform. Rosemary also directed clinical and biothreat platforms, focusing on rapid DNA purification and microfluidic sequencing for pathogen detection.

From 2006 to 2009, Rosemary worked at Network Biosystems as a Scientist. Here, they developed and optimized protocols for DNA purification, PCR amplification, and DNA sequencing. Rosemary also led a Multi-Locus Sequence Typing project on Bacillus cereus and developed a rapid point-of-care diagnostic for Chlamydia trachomatis.

Rosemary'sprofessional journey began at the University of Massachusetts Amherst, where they served as a Graduate Student from 2001 to 2006.

Overall, Rosemary (Turingan) Witkowski has a wealth of experience in DNA analysis and assay development, making their a valuable asset in the field of molecular biology.

Rosemary (Turingan) Witkowski completed their Bachelor's degree in Chemistry at the University of the Philippines. The specific duration of their studies at this institution is unknown. Subsequently, they pursued further education and earned their PhD in Chemistry from the University of Massachusetts Amherst, where they studied from 2001 to 2006.

Links

Peers

View in org chart

Timeline

  • VP, Assay Development and Innovation

    April, 2022 - present

A panel showing how The Org can help with contacting the right person.